QVCGA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. Despite a constructive short-term technical setup (bullish moving averages and positive MACD), options positioning is notably defensive (high put/call open interest), and the latest quarterly fundamentals show shrinking revenue and margin. With no Intellectia buy signals and the stock sitting below near-term resistance, the risk/reward isn’t attractive for an impatient buyer at $10.53.
Trend/structure: Bullish moving-average stack (SMA_5 > SMA_20 > SMA_200) indicates an uptrend bias. Momentum: MACD histogram +0.108 and expanding supports continued upside attempt; RSI(6)=62.54 is neutral-to-strong (not overbought). Levels: Pivot 10.298 is key near-term support; below that, S1 9.706 then S2 9.34. Resistance is close overhead at R1 10.89 (then R2 11.256). Current price (10.53) is above pivot but still below R1, so upside is not confirmed until a clean break above 10.89.
Intellectia Proprietary Trading Signals
News flow is mildly positive and product-driven: QVC introduced new beauty/wellness brands for 2026 (e.g., K18 and others), emphasizing exclusives and distribution via TV + digital + QVC+ streaming. This supports category refresh and potential engagement/traffic catalysts. Technical backdrop is also supportive (uptrend bias).
Fundamental pressure persists: revenue declined YoY and gross margin compressed in the latest reported quarter, which can cap multiple expansion. Options positioning is defensively skewed (high put/call open interest). No notable hedge fund/insider accumulation signals were observed (both neutral). No political/congress trading catalysts were available.
Latest quarter: 2025/Q3. Revenue fell to $2.213B (-5.59% YoY) and gross margin declined to 29.33% (-6.08% YoY), signaling top-line and profitability pressure. Net income improved to -$80M (up 247.83% YoY) and EPS improved to -9.92 (up 242.07% YoY), but results remain loss-making; overall growth trend is mixed (loss narrowing, but weakening sales and margin).
No analyst rating/price target change data was provided, so a clear Wall Street consensus trend can’t be confirmed from this dataset. Pros (likely): any execution in beauty/wellness refresh and omni-channel engagement. Cons (likely): declining revenue/margins and uncertainty reflected in elevated volatility and put-heavy open interest.
